EXPAREL Administered Into the TAP for Analgesia in Subjects Undergoing Open Total Abdominal Hysterectomy
Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the optimal of two different volumes of
EXPAREL 266 mg when administered via infiltration into the transversus abdominis plane (TAP)
for prolonged postoperative analgesia in subjects undergoing open total abdominal
hysterectomy.